All Pharmaceuticals articles – Page 3
-
Blog
Acadia Pharmaceuticals announces chief legal officer
Acadia Pharmaceuticals announced Jennifer Rhodes is joining the company as executive vice president, chief legal officer and secretary.
-
Blog
Tris Pharma appoints chief compliance officer
Tris Pharma announced the appointment of Franchesca Fowler as chief compliance officer and vice president, general counsel.
-
Blog
Maxor names chief compliance and ethics officer
Maxor National Pharmacy Services announced the appointment of Jessica Lee as chief compliance and ethics officer.
-
Blog
CorMedix announces new chief legal officer
Biopharmaceutical company CorMedix announced the appointment of Beth Zelnick Kaufman as executive vice president, chief legal officer and corporate secretary.
-
Premium
Money, size, industry: Multiple factors at play in setting compliance reporting lines
Compliance teams most often report to their firm’s legal department, our “Inside the Mind of the CCO” survey found. However, heavily regulated companies and those with fewer employees saw different trends emerge.
-
Premium
Five compliance triumphs from 2023
A financial services giant’s compliance mea culpa that could serve to benefit the rest of the profession, a chemical company’s praised FCPA settlement, and an example of the value of whistleblowers highlight CW’s annual list of laudable ethics and compliance moments.
-
Blog
Calliditas names group general counsel
Pharmaceutical company Calliditas Therapeutics appointed Brian Gorman as group general counsel.
-
Blog
Petauri Health appoints general counsel
Pharmaceutical services platform Petauri Health announced the appointment of Nicole Kline as vice president, general counsel.
-
News Brief
Mallinckrodt dodges $40M SEC penalty in disclosure violation case
Pharmaceutical company Mallinckrodt, fresh out of its second bankruptcy, was spared having to pay a $40 million penalty levied by the Securities and Exchange Commission for alleged disclosure and accounting failures related to its underpaying of Medicaid rebates.
-
Blog
EuroAPI appoints chief legal, compliance officer
Pharmaceutical ingredients company EuroAPI announced the appointment of Marion Santin as chief legal, compliance, and IP officer, as part of its executive committee.
-
News Brief
Lifecore Biomedical earns FCPA declination for voluntary self-disclosure
Pharmaceuticals company Lifecore Biomedical won’t face prosecution for apparent violations of the Foreign Corrupt Practices Act after satisfying multiple factors of the Department of Justice’s recently updated voluntary self-disclosure policy.
-
News Brief
CCO jailed 4 1/2 years for role in $50M Medicare fraud
The chief compliance officer of a defunct pharmacy holding company was sentenced to 4 1/2 years in prison after being found guilty of conspiracy to commit healthcare fraud and wire fraud earlier this year.
-
News Brief
HHS publishes updated healthcare compliance guidance
New guidance from the Department of Health and Human Services is designed to apply generally to the healthcare industry, from doctors to pharmaceutical manufacturers, and help all such entities self-monitor their compliance and prevent waste, fraud, and abuse.
-
Blog
Amarin names chief legal and compliance officer
Pharmaceuticals company Amarin Corp. announced the appointment of Jonathan Provoost as executive vice president, chief legal and compliance officer.
-
News Brief
Nostrum Labs, CEO to pay up to $50M in DOJ false claims case
Pharmaceuticals firm Nostrum Laboratories and its founder and chief executive officer could pay up to $50 million as part of a settlement with the Department of Justice addressing alleged violations of the False Claims Act by underpaying Medicaid rebates.
-
Blog
Prime Therapeutics appoints chief compliance officer
Prime Therapeutics/Magellan Rx, a pharmacy benefit manager, announced the appointment of Tizgel High as chief compliance officer.
-
News Brief
Lawsuit: Pfizer fired, retaliated against whistleblower who raised FCPA concerns
An ex-Pfizer compliance officer is suing his former employer claiming wrongful termination and whistleblower retaliation after discovering the company allegedly paid $168 million to potentially influential government officials in China.
-
Blog
Earth Science Tech CCO resigns
Pharmaceuticals-geared holding company Earth Science Tech disclosed in a regulatory filing that Chief Compliance Officer Nickolas Tabraue resigned.
-
News Brief
Inotiv discloses FCPA probe into primate importation practices
Inotiv disclosed the Securities and Exchange Commission is investigating potential violations of the Foreign Corrupt Practices Act by the pharmaceutical testing company regarding its importation of nonhuman primates from Asia.
-
News Brief
CCO among 12 individuals charged in DOJ, SEC insider trading sweep
The Department of Justice and Securities and Exchange Commission announced charges against a dozen individuals across four separate insider trading cases, including an alleged scheme involving the chief compliance officer of an international payment processing company.